✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Biocon Ltd

Common Name
Biocon
Country
India
Sector
Healthcare
Industry
Biotechnology
Employees
16,420
Ticker
BIOCON
Exchange
National Stock Exchange of India
Description
Biocon Ltd. is a prominent biopharmaceutical company based in India, specializing in the development and production of innovative and cost-effective medical therapies. The company's primary focus lies...

Biocon's GHG Emissions Data Preview

In 2025, Biocon completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Biocon has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2025202420232022-2019
Total Scope 1
27,951a
31,764a
39,712a
Total Scope 2
Unspecified Calculation Method
114,092a
104,028a
119,745a
Total Scope 3
283,819a
248,732a
224,217a
Total Scope 1 Revenue Intensity (tCO2e/$M)
15.8658a
18.6597a
29.8184a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=BIOCON&reporting_period=2025"

Verified Sources Behind Biocon’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Biocon's ESG Data Spreadsheet 2025
b. Biocon's ESG Report 2022

Insights into Biocon's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Biocon amounted to 142,043 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Biocon increased by 4.6%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Biocon's Scope 1 Emissions Over Time

20212022202320242025020 k40 k60 k80 ktCO2e+11%-36%-20%-12%
  • Total Scope 1
  • Year-over-Year Change

What are Biocon's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Biocon were 27,951 metric tons of CO₂ equivalent (tCO₂e).a

Has Biocon reduced its Scope 1 emissions over time?

Since 2021, Biocon's Scope 1 emissions have decreased by 50.08%, reflecting a declining long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2024), Biocon's Scope 1 emissions decreased by 12%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Biocon's Scope 2 emissions?

In 2025, Biocon reported Scope 2 greenhouse gas (GHG) emissions of 114,092 tCO₂e without specifying the calculation method.a

Has Biocon reduced its Scope 2 emissions over time?

Since 2021, Biocon's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 10.54%, reflecting a declining long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2024), Biocon's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Biocon's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Biocon use for Scope 2 reporting?

In 2025, Biocon reported its Scope 2 emissions using an unspecified methodology.a

Biocon's Scope 2 Emissions Over Time

20212022202320242025035 k70 k105 k140 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Biocon's Value Chain Emissions

In 2025, Biocon reported 283,819 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Biocon includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2024, reflecting improved emissions accounting practices and greater transparency across the company's value chaina

Biocon's Scope 3 Emissions Over Time

202320242025075 k150 k225 k300 ktCO2e+11%+14%
  • Total Scope 3
  • Year-over-Year Change

What are Biocon's Scope 3 emissions?

In 2025, Biocon reported total Scope 3 emissions of 283,819 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 99.69% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.31% came from downstream activities like product use, distribution, and end-of-life treatment.a

Compared to the previous year (2024), Biocon's Scope 3 emissions increased by 14.11%, suggesting that the company faced challenges in reducing emissions across its value chain.a

What categories of Scope 3 emissions does Biocon disclose?

In 2025, Biocon reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Biocon's Scope 3 emissions?

In 2025, the largest contributors to Biocon's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 176,779 tCO₂e (62.29%)
  • Fuel- and Energy-Related Services (Cat. 3): 37,756 tCO₂e (13.3%)
  • Capital Goods (Cat. 2): 32,761 tCO₂e (11.54%)

Biocon's Scope 3 Emissions by Categories

Fuel- andEnergy-RelatedServices (Cat. 3)(13.3%)Capital Goods(Cat. 2)(11.5%)Purchased Goods andServices (Cat. 1)(62.3%)

Insights into Biocon’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Biocon reported Scope 1 greenhouse gas (GHG) emissions of 27,951 tCO₂e and total revenues of USD 1,762 millions. This translates into an emissions intensity of 15.87 tCO₂e per millions USD.a

Biocon's Scope 1 Emissions Intensity Compared to Peers

101001,00010,000100,000Scope 1 Emissions (tCO2e)10502002,00010,000Revenues (Millions of USD)RemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MFortrea HoldingsYear: 2023Scope 1: 864 tCO2eRevenue: $M 3,109Scope 1 Intensity: 0.28 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MBavarian NordicYear: 2024Scope 1: 4,111 tCO2eRevenue: $M 797Scope 1 Intensity: 5.16 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MAscendis PharmaYear: 2024Scope 1: 62 tCO2eRevenue: $M 450Scope 1 Intensity: 0.14 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,291Scope 1 Intensity: 0.04 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 594Scope 1 Intensity: 66.24 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MZealand PharmaYear: 2025Scope 1: 72 tCO2eRevenue: $M 1,452Scope 1 Intensity: 0.05 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 759Scope 1 Intensity: 9.10 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MALK-AbelloYear: 2023Scope 1: 10,256 tCO2eRevenue: $M 714Scope 1 Intensity: 14.36 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,248Scope 1 Intensity: 10.66 tCO2e/$MBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 199.08 tCO2e/$MConcord BiotechYear: 2025Scope 1: 13 tCO2eRevenue: $M 140Scope 1 Intensity: 0.09 tCO2e/$MBioconYear: 2025Scope 1: 27,951 tCO2eRevenue: $M 1,762Scope 1 Intensity: 15.87 tCO2e/$M

How does Biocon's GHG emissions intensity compare to its peers?

In 2025, Biocon reported a Scope 1 emissions intensity of 15.87 tCO₂e per millions USD. Compared to the peer group median of 3.8, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Biocon rank on GHG emissions intensity within its industry?

In 2025, Biocon ranked 20 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Biocon among the least efficient performers, with one of the highest emissions intensities in its sector.a

Insights into Biocon's Total Carbon Footprint

In 2025, Biocon reported a total carbon footprint of 425,862 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 10.75% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Biocon's total carbon footprint was Scope 3 emissions, accounting for 66.65% of the company's total carbon footprint, followed by Scope 2 emissions at 26.79%.a

Want Full Access to Biocon's GHG Emissions Dataset?
Start 30-Day Free Trial